ZimVie (ZIMV) said Friday that it is withdrawing its fiscal 2025 guidance as it prepares to go private following a recently announced $731 million acquisition deal with Archimed.
The deal is slated to be completed by the end of this year.
ZimVie said it will report Q2 financial results and file its quarterly report on Form 10-Q after market close on July 30.